Affiliation:
1. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology
Abstract
Introduction. The development of intrauterine growth restriction (IUGR) begins with fertilization and trophoblast invasion. IUGR is manifested in a decrease in fetal growth rate. However, data on risk factors for fetal growth retardation, their combination with various chronic diseases in a pregnant woman are contradictory.Objective. To study the features of the course of pregnancy, childbirth, the health status of newborns with IUGR. Materials and methods. The study was a retrospective cohort study. At the first stage, we analyzed 1574 birth histories with a diagnosis of IUGR, placental insufficiency, women with normal pregnancy who gave birth (2016–2021). According to the inclusion and exclusion criteria, 408 women were included in the study. The women were divided into 2 groups. The first group included 202 pregnant women with a diagnosis of IUGR. In the second Group – 206 pregnant women with normal pregnancy, without IUGR, delivered at the time corresponding to the terms in the main group.Results. We have clarified the risk factors and premorbid conditions involved in the development of IUGR (somatic and gynecological morbidity, pregnancy course). Their analysis is necessary to predict IUGR. The analysis of the timing and method of delivery in the studied groups was carried out. A higher incidence of complications in the early neonatal period was revealed when assessing the health status of newborns with IUGR.Conclusion. Thus, the study of the mechanisms of IUGR formation in the future will allow the development of modern pathogenetic approaches to prevention and treatment.
Reference16 articles.
1. Soldatova E.E., Kan N.E., Tyutyunnik V.L., Volochaeva M.V. Fetal growth retardation from the position of fetal programming. Akusherstvo i Ginekologiya (Russian Federation). 2022;(8):5–10. (In Russ.) https://doi.org/10.18565/aig.2022.8.5-10.
2. Romo A., Carceller R., Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr Endocrinol Rev. 2009;6(3):332–336. Available at: https://pubmed.ncbi.nlm.nih.gov/19404231/.
3. Marcondes L., Nardozza M., Caetano A.C.R., Zamarian A.C., Mazzola J.B., Silva C.P. et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061–1077. https://doi.org/10.1007/s00404-017-4341-9.
4. Demicheva E., Crispi F. Long-term follow-up of intrauterine growth restriction: cardiovascular disorders. Fetal Diagn Ther. 2014;36(2):143–153. https://doi.org/10.1159/000353633.
5. Armengaud J.B., Yzydorczyk C., Siddeek B., Peyter A.C., Simeoni U. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021;99:168–176. https://doi.org/10.1016/j.reprotox.2020.10.005.